IRadimed

IRadimed Net Margin

The Net Profit Margin of IRadimed (IRMD) as of Oct 10, 2026 is 26.82 %. In the previous year, Net Profit Margin was 26.26 % — a change of 2.13% (higher).

Net Margin

26.82 %

YoY

2.13%

Last updated:

Net Profit Margin of IRadimed is 2025 26.82 % . Net Profit Margin of IRadimed was 2024 26.26 % . It decreases by 2.13% higher compared to the previous year.

IRadimed's net margin stands at 26.8%, up from 22.3% several years earlier.

The IRadimed Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
20.71 USD
Jan 1, 2019
25.00 USD
Jan 1, 2020
4.32 USD
Jan 1, 2021
22.30 USD
Jan 1, 2022
24.06 USD
Jan 1, 2023
26.22 USD
Jan 1, 2024
26.26 USD
Jan 1, 2025
26.82 USD
The IRadimed Net Margin history
YEARNet MarginYoY
26.82 %+2.13%
26.26 %+0.14%
26.22 %+8.97%
24.06 %+7.91%
22.30 %+416.70%
4.32 %-82.74%
25.00 %+20.74%
20.71 %+856.42%
2.17 %-90.25%
22.20 %-6.85%
23.83 %+81.95%
13.10 %+7,569.09%
0.17 %+35.87%
0.13 %—
Access this data via the Eulerpool API

IRadimed Stock analysis

What does IRadimed do? IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IRadimed stock

Net Profit Margin of IRadimed is 26.82 % in 2025.

Net Profit Margin of IRadimed changed from 26.26 % to 26.82 %, representing a 2.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin IRadimed since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's IRadimed with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

Margins — IRadimed

All Key Metrics — IRadimed